AV

Amish Vyas Pravinchandra

Active Director Nominee Director DIN 00168292
DIN 00168292 First appointment Jan 2003 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 3 active board seats
Past companies 13 historical roles
Total affiliations 16 Since Jan 2003
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 15 Jan 2003
Active appointments 3
Total timeline records 16

Amish Vyas Pravinchandra (DIN 00168292) has 16 recorded board appointments in Indian companies, the first from January 2003, of which 3 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 2003
Enaltec Pharma Research Private Limited Nominee Director · 2026 – present
Current
Enaltec Labs Private Limited Nominee Director · 2025 – present
Current
Ai4pharma Tech Limited Director · 2024 – present
Current
Glochem Industries Private Limited Additional Director · 2025 – 2025
Previous
Chieron Active Ingredients Private Limited Additional Director · 2025 – 2025
Previous
Audhataam Pharmaceuticals Private Limited Additional Director · 2025 – 2025
Previous
Baxter Pharmaceuticals India Private Limited Additional Director · 2017 – 2017
Previous
Dorizoe Lifesciences Limited Additional Director · 2015 – 2015
Previous
Previous
Zed Supplychain Limited Director · 2008 – 2008
Previous
Claris Infrastructure Limited Director · 2007 – 2017
Previous
Claris Lifesciences Limited Whole-Time Director · 2006 – 2009
Previous
Dialys Healthcare Private Limited Director · 2005 – 2009
Previous
Medical Technologies Limited Director · 2005 – 2005
Previous
Xcelris Labs Limited Director · 2005 – 2009
Previous
Healthnext Limited Director · 2003 – 2009
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available